Demei Huang

988 total citations
37 papers, 701 citations indexed

About

Demei Huang is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, Demei Huang has authored 37 papers receiving a total of 701 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 14 papers in Pulmonary and Respiratory Medicine and 9 papers in Genetics. Recurrent topics in Demei Huang's work include Heme Oxygenase-1 and Carbon Monoxide (15 papers), High Altitude and Hypoxia (9 papers) and Inflammasome and immune disorders (8 papers). Demei Huang is often cited by papers focused on Heme Oxygenase-1 and Carbon Monoxide (15 papers), High Altitude and Hypoxia (9 papers) and Inflammasome and immune disorders (8 papers). Demei Huang collaborates with scholars based in China, United States and Hong Kong. Demei Huang's co-authors include Caixia Pei, Yongcan Wu, Zhenxing Wang, Yilan Wang, Shihua Shi, Zherui Shen, Fei Wang, Yacong He, Xiaomin Wang and Xiaomin Wang and has published in prestigious journals such as Frontiers in Microbiology, Biochemical Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Demei Huang

34 papers receiving 685 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Demei Huang China	16	378	220	121	98	72	37	701
Zhenxing Wang China	16	412 1.1×	238 1.1×	134 1.1×	98 1.0×	68 0.9×	63	808
Caixia Pei China	15	366 1.0×	216 1.0×	118 1.0×	98 1.0×	53 0.7×	33	644
Yongcan Wu China	15	362 1.0×	218 1.0×	117 1.0×	98 1.0×	51 0.7×	30	637
Shihua Shi China	15	349 0.9×	202 0.9×	112 0.9×	81 0.8×	57 0.8×	36	629
Ilijana Grigorov Serbia	15	283 0.7×	170 0.8×	126 1.0×	99 1.0×	15 0.2×	60	790
Zherui Shen China	13	251 0.7×	175 0.8×	97 0.8×	56 0.6×	18 0.3×	24	419
Nuray Varol Türkiye	14	404 1.1×	45 0.2×	131 1.1×	57 0.6×	22 0.3×	31	766
Fa Sun China	14	267 0.7×	205 0.9×	73 0.6×	18 0.2×	30 0.4×	49	610
Yu‐Wen Chen Taiwan	12	291 0.8×	87 0.4×	44 0.4×	54 0.6×	18 0.3×	29	622
Xiaoli Zeng China	15	189 0.5×	107 0.5×	58 0.5×	94 1.0×	23 0.3×	45	629

Countries citing papers authored by Demei Huang

Since Specialization

Citations

This map shows the geographic impact of Demei Huang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Demei Huang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Demei Huang more than expected).

Fields of papers citing papers by Demei Huang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Demei Huang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Demei Huang. The network helps show where Demei Huang may publish in the future.

Co-authorship network of co-authors of Demei Huang

This figure shows the co-authorship network connecting the top 25 collaborators of Demei Huang. A scholar is included among the top collaborators of Demei Huang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Demei Huang. Demei Huang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chen, Qian, Demei Huang, Junling Liu, et al.. (2025). The gut microbiota in high-altitude medicine: intersection of hypoxic adaptation and disease management. Frontiers in Microbiology. 16. 1705487–1705487.

Shen, Zherui, Qian Chen, Chen Chen, et al.. (2025). Astragaloside II pretreatment alleviates PM2.5-induced lung injury in mice via MAPK/Nrf2/GPX4 axis-mediated suppression of ferroptosis. Ecotoxicology and Environmental Safety. 302. 118613–118613.

Wang, Yilan, Ying Liu, Caixia Pei, et al.. (2024). Notoginsenoside R1 treatment facilitated Nrf2 nuclear translocation to suppress ferroptosis via Keap1/Nrf2 signaling pathway to alleviated high-altitude myocardial injury. Biomedicine & Pharmacotherapy. 175. 116793–116793. 13 indexed citations

Huang, Demei, Yilan Wang, Caixia Pei, et al.. (2024). Pre-treatment with notoginsenoside R1 from Panax notoginseng protects against high-altitude-induced pulmonary edema by inhibiting pyroptosis through the NLRP3/caspase-1/GSDMD pathway. Biomedicine & Pharmacotherapy. 180. 117512–117512. 6 indexed citations

Liu, Junling, Caixia Pei, Zherui Shen, et al.. (2024). Preconditioning with Ginsenoside Rg3 mitigates cardiac injury induced by high-altitude hypobaric hypoxia exposure in mice by suppressing ferroptosis through inhibition of the RhoA/ROCK signaling pathway. Journal of Ethnopharmacology. 337(Pt 2). 118861–118861. 11 indexed citations

Huang, Demei, Zherui Shen, Caixia Pei, et al.. (2023). Sipeimine attenuates PM2.5-induced lung toxicity via suppression of NLRP3 inflammasome-mediated pyroptosis through activation of the PI3K/AKT pathway. Chemico-Biological Interactions. 376. 110448–110448. 14 indexed citations

Pei, Caixia, Yilan Wang, Zherui Shen, et al.. (2023). Notoginsenoside R1 protects against hypobaric hypoxia-induced high-altitude pulmonary edema by inhibiting apoptosis via ERK1/2-P90rsk-BAD ignaling pathway. European Journal of Pharmacology. 959. 176065–176065. 12 indexed citations

Huang, Demei, Caixia Pei, Zherui Shen, et al.. (2023). Rosavidin protects against PM2.5-induced lung toxicity via inhibition of NLRP3 inflammasome-mediated pyroptosis by activating the PI3K/AKT pathway. Biochemical Pharmacology. 213. 115623–115623. 8 indexed citations

Shi, Shihua, Demei Huang, Yongcan Wu, et al.. (2023). Salidroside pretreatment alleviates PM2.5 caused lung injury via inhibition of apoptosis and pyroptosis through regulating NLRP3 Inflammasome. Food and Chemical Toxicology. 177. 113858–113858. 17 indexed citations

10.

Shen, Zherui, Demei Huang, Caixia Pei, et al.. (2023). Protective effects of Eleutheroside E against high-altitude pulmonary edema by inhibiting NLRP3 inflammasome-mediated pyroptosis. Biomedicine & Pharmacotherapy. 167. 115607–115607. 13 indexed citations

11.

Wang, Yilan, Zherui Shen, Demei Huang, et al.. (2022). Sipeimine ameliorates PM2.5-induced lung injury by inhibiting ferroptosis via the PI3K/Akt/Nrf2 pathway: A network pharmacology approach. Ecotoxicology and Environmental Safety. 239. 113615–113615. 53 indexed citations

12.

Huang, Demei, Shihua Shi, Yilan Wang, et al.. (2022). Astragaloside IV alleviates PM2.5-caused lung toxicity by inhibiting inflammasome‐mediated pyroptosis via NLRP3/caspase-1 axis inhibition in mice. Biomedicine & Pharmacotherapy. 150. 112978–112978. 28 indexed citations

13.

Wang, Xiaomin, Shuiqin Li, Yongcan Wu, et al.. (2022). Effect of omega-3 fatty acids on TH1/TH2 polarization in individuals with high exposure to particulate matter ≤ 2.5 μm (PM2.5): a randomized, double-blind, placebo-controlled clinical study. Trials. 23(1). 179–179. 1 indexed citations

14.

Shi, Shihua, Fei Wang, Huan Yao, et al.. (2022). Oral Chinese Herbal Medicine on Immune Responses During Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Frontiers in Medicine. 8. 685734–685734. 17 indexed citations

15.

Wang, Xiaoming, Yilan Wang, Demei Huang, et al.. (2022). Astragaloside IV regulates the ferroptosis signaling pathway via the Nrf2/SLC7A11/GPX4 axis to inhibit PM2.5-mediated lung injury in mice. International Immunopharmacology. 112. 109186–109186. 106 indexed citations

16.

Pei, Caixia, Fei Wang, Demei Huang, et al.. (2021). Astragaloside IV Protects from PM2.5-Induced Lung Injury by Regulating Autophagy via Inhibition of PI3K/Akt/mTOR Signaling in vivo and in vitro. Journal of Inflammation Research. Volume 14. 4707–4721. 45 indexed citations

17.

Wu, Yongcan, Demei Huang, Xiaomin Wang, et al.. (2021). Suppression of NLRP3 inflammasome by Platycodin D via the TLR4/MyD88/NF-κB pathway contributes to attenuation of lipopolysaccharide induced acute lung injury in rats. International Immunopharmacology. 96. 107621–107621. 34 indexed citations

18.

Wu, Yongcan, Wei Xiao, Caixia Pei, et al.. (2020). Astragaloside IV alleviates PM2.5-induced lung injury in rats by modulating TLR4/MyD88/NF-κB signalling pathway. International Immunopharmacology. 91. 107290–107290. 38 indexed citations

19.

Wu, Yongcan, Caixia Pei, Xiaomin Wang, et al.. (2020). Effect of probiotics on nasal and intestinal microbiota in people with high exposure to particulate matter ≤ 2.5 μm (PM2.5): a randomized, double-blind, placebo-controlled clinical study. Trials. 21(1). 850–850. 9 indexed citations

20.

Zhu, Yin, Xu Shu, Yong Xie, et al.. (2008). Effect of Helicobacter pylori eradication on oncogenes and cell proliferation. European Journal of Clinical Investigation. 38(9). 628–633. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact